Talphera (TLPH) Revenue (2011 - 2025)

Talphera's (TLPH) quarterly Revenue came in at $1000.0 in Q3 2025, down 96.3% quarter-over-quarter from $27000.0 in Q1 2025.

Talphera (TLPH) Revenue (2011 - 2025) Analysis & Trends

Talphera's Revenue history runs 14 years deep, the most recent figure standing at $1000.0 for Q3 2025.

  • On a quarterly basis, Revenue changed N/A year-over-year to $1000.0 in Q3 2025; TTM through Mar 2026 was $1000.0, a 96.3% decrease from a year earlier, with the FY2025 full-year figure at $28000.0, changed N/A from the prior year.
  • Revenue fell to $1000.0 in Q3 2025 per TLPH's latest filing, from $27000.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.7 million in Q3 2021 and bottomed at $1000.0 in Q3 2025.
  • The 4-year median for Revenue is $281000.0 (2023), against an average of $388909.1.
  • Biggest YoY gain for Revenue was 32.38% in 2021; the steepest drop was 99.73% in 2021.
  • Year by year, Revenue stood at $2000.0 in 2021, then soared by 22000.0% to $442000.0 in 2022, then plunged by 36.43% to $281000.0 in 2023, then sank by 99.64% to $1000.0 in 2025.
  • Per Business Quant, the three latest TLPH Revenue figures stand at $1000.0 (Q3 2025), $27000.0 (Q1 2025), and $281000.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.98 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.26 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 6.98 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 781.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 3.51 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 814.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.37 Bn
10 Talphera 47.31 Mn 9.48 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 1,000.00
Mar 31, 2025 27,000.00
Dec 31, 2023 281,000.00
Sep 30, 2023 117,000.00
Jun 30, 2023 253,000.00
Mar 31, 2023 501,000.00
Mar 31, 2022 442,000.00
Dec 31, 2021 2,000.00
Sep 30, 2021 1.70 Mn
Jun 30, 2021 443,000.00
Mar 31, 2021 511,000.00
Dec 31, 2020 738,000.00
Sep 30, 2020 1.37 Mn
Jun 30, 2020 2.92 Mn
Mar 31, 2020 386,000.00
Dec 31, 2019 475,000.00
Sep 30, 2019 608,000.00
Jun 30, 2019 941,000.00
Mar 31, 2019 265,000.00
Dec 31, 2018 613,000.00